| 标题 |
Dosimetry Results from the Phase 1b/3 ACTION-1 Trial of [ 225 Ac]Ac-DOTATATE (RYZ101) in Patients with Somatostatin Receptor–Expressing, Well-Differentiated GEP-NETs |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Nuclear Medicine 作者:George Sgouros; Gary A. Ulaner; Bin He; Michael Ghaly; Eric Frey; et al 出版日期:2026-06-04 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)